\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ at\\ follow\\-up\\ visit\\ revealed\\ swelling\\,\\ erythema\\,\\ and\\ tenderness\\ to\\ palpation\\ at\\ the\\ medial\\ ankle\\.\ \(0\)\
\-\ treatment\\ for\\ brodie\\â\\€\\™s\\ abscess\\ includes\\ surgical\\ debridement\\ and\\ antibiotic\\ therapy\\.\ \(0\)\
\-\ histopathologic\\ evaluation\\ showed\\ granulation\\ tissue\\,\\ acute\\ and\\ chronic\\ inflammation\\,\\ dense\\ fibroconnective\\ tissue\\,\\ and\\ bone\\ fragments\\.\ \(0\)\
\-\ cultures\\ grew\\ staphylococcus\\ aureus\\.\ \(0\)\
\-\ figure\\ 1\\:\\ \\ initial\\ anteroposterior\\ \\(a\\-p\\)\\ radiograph\\ of\\ the\\ right\\ distal\\ tibia\\ and\\ fibula\\ 15\\ months\\ prior\\ to\\ the\\ current\\ presentation\\ showed\\ no\\ evidence\\ of\\ fracture\\ and\\ mild\\ soft\\ tissue\\ swelling\\ around\\ the\\ lateral\\ malleolus\\.\\ \\ incidentally\\,\\ a\\ lucent\\ lesion\\ with\\ a\\ well\\ defined\\ cortical\\ margin\\ was\\ found\\ along\\ the\\ lateral\\ distal\\ tibia\\,\\ consistent\\ with\\ a\\ nonossifying\\ fibroma\\.\ \(0\)\
\-\ figure\\ 2\\:\\ \\ follow\\-up\\ a\\-p\\ radiograph\\ of\\ the\\ right\\ distal\\ tibia\\ and\\ fibula\\ 15\\ months\\ after\\ the\\ initial\\ injury\\ shows\\ a\\ bilocular\\ lytic\\ lesion\\ of\\ the\\ metaphysis\\ and\\ a\\ unilocular\\ lytic\\ lesion\\ of\\ the\\ epiphysis\\ at\\ the\\ medial\\ aspect\\ of\\ the\\ tibia\\.\\ the\\ lesions\\ are\\ surrounded\\ by\\ a\\ well\\ defined\\ sclerotic\\ border\\ with\\ benign\\-appearing\\ periosteal\\ reaction\\ and\\ mild\\ soft\\ tissue\\ swelling\\ medially\\.\\ the\\ metaphyseal\\ lesions\\ extend\\ across\\ the\\ physis\\ into\\ the\\ epiphysis\\.\\ there\\ are\\ no\\ fracture\\ lucencies\\ and\\ the\\ joint\\ spaces\\ are\\ maintained\\.\\ \\ the\\ nonossifying\\ fibroma\\ of\\ the\\ lateral\\ distal\\ tibia\\ is\\ unchanged\\.\ \(0\)\
\-\ figure\\ 3\\:\\ \\ a\\ tc\\-99m\\ hdp\\ bone\\ scan\\ demonstrates\\ increased\\ radiotracer\\ uptake\\ at\\ the\\ distal\\ tibial\\ meta\\-epiphysis\\,\\ most\\ marked\\ on\\ the\\ medial\\ aspect\\ of\\ the\\ epiphysis\\.\ \(0\)\
\-\ figure\\ 4\\:\\ \\ axial\\ t1\\-weighted\\ mr\\ image\\ of\\ right\\ leg\\ reveals\\ multiple\\ well\\ defined\\ low\\ signal\\ intensity\\ masses\\ surrounded\\ by\\ a\\ thick\\ medium\\ intensity\\ rim\\ with\\ a\\ low\\ signal\\ intensity\\ periphery\\.\\ the\\ tibial\\ metaphyseal\\ component\\ measures\\ 2\\.1cm\\ longitudinal\\ x\\ 1\\.6cm\\ transverse\\ x\\ 2\\.1cm\\ ap\\.\\ \\ the\\ epiphyseal\\ component\\ measures\\ 2\\ cm\\ longitudinal\\ x\\ 2\\.3cm\\ transverse\\ x\\ 3cm\\ ap\\.\\ \\ the\\ inflammatory\\ process\\ extends\\ posteromedially\\ through\\ the\\ cortex\\ of\\ the\\ tibial\\ epiphysis\\ to\\ involve\\ the\\ adjacent\\ soft\\ tissues\\.\\ \ \(0\)\
\-\ figure\\ 5\\:\\ \\ on\\ axial\\ t2\\-weighted\\ fat\\ saturated\\ mr\\ image\\ of\\ the\\ right\\ leg\\,\\ masses\\ become\\ high\\-signal\\ intensity\\ surrounded\\ by\\ low\\-signal\\ intensity\\ rims\\.\\ the\\ high\\ signal\\-intensity\\ inflammation\\ extends\\ into\\ the\\ adjacent\\ soft\\ tissues\\.\\ there\\ is\\ a\\ low\\ signal\\ intensity\\ thickening\\ of\\ the\\ soft\\ tissues\\ medially\\ which\\ extends\\ anteriorly\\ to\\ the\\ anterior\\ aspect\\ of\\ the\\ anterior\\-tibial\\ tendon\\ and\\ posteriorly\\ to\\ the\\ lateral\\ aspect\\ of\\ the\\ tibial\\ tendon\\,\\ flexor\\ digitorum\\ longus\\ tendon\\ and\\ hallucis\\ longus\\ tendon\\.\\ \\ there\\ are\\ non\\-enhancing\\ foci\\ within\\ the\\ soft\\ tissue\\ consistent\\ with\\ extensive\\ inflammation\\.\ \(0\)\
\-\ figure\\ 6\\:\\ \\ axial\\ t1\\-weighted\\ mr\\ image\\ after\\ contrast\\ demonstrates\\ well\\ defined\\ masses\\ with\\ non\\-enhancing\\ centers\\,\\ enhancing\\ thick\\ rim\\,\\ and\\ non\\-enhancing\\ periphery\\.\\ \\ the\\ non\\-enhancing\\ central\\ lesions\\ correspond\\ to\\ the\\ low\\ signal\\ intensity\\ centers\\ seen\\ on\\ t1\\-weighted\\ mr\\ and\\ high\\ signal\\ intensity\\ centers\\ seen\\ on\\ t2\\-weighted\\ mr\\,\\ which\\ together\\ is\\ consistent\\ with\\ necrosis\\.\\ the\\ epiphyseal\\ lesion\\ expands\\ through\\ the\\ anteromedial\\ border\\ of\\ the\\ tibia\\ with\\ extension\\ of\\ the\\ abscess\\ into\\ the\\ adjacent\\ soft\\ tissues\\.\\ \\ high\\-signal\\-intensity\\ bone\\ marrow\\ edema\\ extends\\ 5\\.5cm\\ proximally\\ into\\ the\\ distal\\ tibial\\ diaphysis\\ from\\ the\\ site\\ of\\ the\\ lesions\\.\ \(0\)\
\-\ brodie\\â\\€\\™s\\ abscess\ \(0\)\
\-\ brodie\\â\\€\\™s\\ abscess\ \(0\)\
\-\ eosinophilic\\ granuloma\\.\ \(2\)\
\-\ 14\\ year\\ old\\ boy\\ presented\\ initially\\ for\\ a\\ sprained\\ right\\ ankle\\.\\ \\ no\\ abnormalities\\ were\\ found\\ at\\ that\\ time\\.\\ \\ the\\ patient\\ returned\\ to\\ clinic\\ after\\ 15\\ months\\ due\\ to\\ increased\\ swelling\\ and\\ pain\\ in\\ the\\ right\\ ankle\\ over\\ a\\ 6\\ month\\ period\\.\ \(0\)\
\-\ in\\ the\\ 1830\\â\\€\\™s\\,\\ sir\\ benjamin\\ collins\\ brodie\\ recognized\\ a\\ chronic\\ inflammatory\\ process\\ in\\ the\\ tibia\\ with\\ no\\ acute\\ symptoms\\ or\\ known\\ precipitating\\ infection\\.\\ this\\ rare\\ lesion\\,\\ known\\ today\\ as\\ a\\ brodie\\â\\€\\™s\\ abscess\\,\\ is\\ a\\ localized\\ type\\ of\\ subacute\\ or\\ chronic\\ pyogenic\\ osteomyelitis\\.\\ pathogenesis\\ is\\ due\\ to\\ an\\ insidious\\ bacteremia\\ with\\ septic\\ emboli\\ to\\ a\\ normal\\ or\\ minimally\\ traumatized\\ long\\ bone\\,\\ often\\ from\\ an\\ infection\\ with\\ staphylococcus\\ aureus\\.\\ the\\ lesion\\ is\\ predominant\\ in\\ young\\ males\\ with\\ unfused\\ epiphyseal\\ plates\\,\\ typically\\ presenting\\ during\\ the\\ second\\ decade\\ of\\ life\\.\\ brodie\\â\\€\\™s\\ abscess\\ is\\ described\\ as\\ a\\ small\\,\\ eccentric\\,\\ localized\\,\\ lytic\\ lesion\\ with\\ surrounding\\ reactive\\ sclerosis\\.\\ it\\ is\\ characteristically\\ found\\ in\\ the\\ metaphyseal\\ region\\ of\\ long\\ bones\\ of\\ the\\ lower\\ extremity\\,\\ most\\ commonly\\ in\\ the\\ tibia\\.\\ the\\ usual\\ presenting\\ complaint\\ is\\ recurrent\\ pain\\ and\\ localized\\ swelling\\;\\ systemic\\ symptoms\\ are\\ typically\\ absent\\.\ \(0\)\
\-\ radiographs\\ of\\ a\\ brodie\\â\\€\\™s\\ abscess\\ often\\ demonstrate\\ a\\ localized\\ area\\ of\\ radiolucency\\ with\\ surrounding\\ sclerosis\\.\\ the\\ lucent\\ region\\ is\\ commonly\\ located\\ in\\ the\\ metaphysis\\ where\\ it\\ may\\ extend\\ to\\ the\\ growth\\ plate\\ by\\ a\\ tortuous\\ channel\\.\\ \\ detection\\ of\\ this\\ focal\\ metaphyseal\\ abscess\\ with\\ involvement\\ of\\ the\\ growth\\ plate\\ is\\ diagnostic\\ for\\ osteomyelitis\\.\\ conventional\\ radiographs\\ should\\ be\\ the\\ initial\\ imaging\\ study\\ for\\ evaluating\\ osteomyelitis\\ although\\,\\ in\\ early\\ osteomyelitis\\ they\\ are\\ usually\\ normal\\ or\\ may\\ show\\ soft\\ tissue\\ swelling\\ or\\ benign\\ periosteal\\ reaction\\.\ \(0\)\
\-\ bone\\ scans\\ are\\ more\\ sensitive\\ than\\ conventional\\ x\\-rays\\ for\\ the\\ early\\ detection\\ of\\ osteomyelitis\\ although\\ not\\ as\\ sensitive\\ as\\ mr\\ imaging\\.\\ \\ a\\ focal\\ area\\ of\\ radiopharmaceutical\\ uptake\\ at\\ the\\ site\\ of\\ suspected\\ infection\\ would\\ suggest\\ a\\ brodie\\â\\€\\™s\\ abscess\\.\\ both\\ brodie\\â\\€\\™s\\ abscesses\\ and\\ eosinophilic\\ granulomas\\ show\\ radiopharmaceutical\\ uptake\\ and\\ therefore\\ this\\ cannot\\ be\\ used\\ as\\ a\\ distinguishing\\ feature\\.\ \(0\)\
\-\ magnetic\\ resonance\\ \\(mr\\)\\ imaging\\ provides\\ a\\ greater\\ accuracy\\ in\\ delineating\\ the\\ extent\\ of\\ disease\\,\\ a\\ more\\ rapid\\ evaluation\\.\\ furthermore\\,\\ mr\\ imaging\\ possesses\\ a\\ high\\ sensitivity\\ in\\ the\\ detection\\ of\\ bone\\ infection\\.\\ on\\ t1\\-weighted\\ mr\\ images\\,\\ subacute\\ osteomyelitis\\ with\\ brodie\\â\\€\\™s\\ abscess\\ presents\\ as\\ a\\ low\\-intensity\\ signal\\ mass\\ with\\ low\\-signal\\-intensity\\ rim\\ that\\ becomes\\ a\\ high\\-intensity\\ signal\\ mass\\ with\\ a\\ thick\\,\\ low\\-intensity\\ rim\\ on\\ t2\\ weighted\\ mr\\ images\\.\\ the\\ abscess\\ may\\ rarely\\ extend\\ into\\ the\\ cortex\\ and\\ into\\ soft\\ tissues\\.\\ in\\ addition\\,\\ the\\ infection\\ may\\ rarely\\ traverse\\ the\\ open\\ growth\\ plate\\,\\ to\\ involve\\ the\\ epiphysis\\.\\ other\\ findings\\ of\\ chronic\\ osteomyelitis\\ include\\ cortical\\ bone\\ thickening\\,\\ sequestra\\,\\ sinus\\ tracts\\ to\\ the\\ adjacent\\ soft\\ tissues\\.\\ post\\-contrast\\ mr\\ images\\ show\\ a\\ non\\-enhancing\\ mass\\ with\\ enhancing\\ periphery\\.\ \(0\)\
\-\ on\\ the\\ imaging\\ studies\\,\\ our\\ patient\\ showed\\ findings\\ consistent\\ with\\ a\\ brodie\\â\\€\\™s\\ abscess\\ with\\ additional\\ more\\ unusual\\ findings\\ of\\ extension\\ across\\ the\\ growth\\ plate\\ into\\ the\\ epiphysis\\ and\\ cortical\\ invasion\\ into\\ adjacent\\ soft\\ tissues\\.\\ alternate\\ diagnoses\\ in\\ the\\ differential\\ can\\ be\\ excluded\\ by\\ the\\ absence\\ of\\ a\\ lesion\\ 15\\ months\\ prior\\ to\\ detection\\ in\\ this\\ skeletally\\ immature\\ youth\\.\\ histopathologic\\ confirmation\\ with\\ and\\ positive\\ cultures\\ for\\ staphylococcus\\ aureus\\,\\ however\\,\\ provide\\ definitive\\ diagnosis\\ of\\ a\\ brodie\\â\\€\\™s\\ abscess\\.\ \(0\)\
\-\ treatment\\ for\\ brodie\\â\\€\\™s\\ abscess\\ includes\\ surgical\\ debridement\\ and\\ antibiotic\\ therapy\\.\\ a\\ sterile\\ abscess\\ may\\ be\\ treated\\ without\\ antibiotics\\ only\\ if\\ there\\ is\\ symptomatic\\ improvement\\ and\\ radiographic\\ regression\\ of\\ the\\ lesion\\.\\ more\\ aggressive\\ treatment\\,\\ such\\ debridement\\ followed\\ by\\ bone\\ grafting\\,\\ may\\ be\\ needed\\ for\\ abscesses\\ that\\ form\\ slightly\\ before\\ or\\ after\\ bone\\ maturation\\ and\\ do\\ not\\ resolve\\ with\\ surgical\\ treatment\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ brodie\\:\\ 0\\.07353659829589199\ \(0\)\
\-\ abscess\\:\\ 0\\.03463892620684958\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.028378074884949513\ \(0\)\
\-\ s\\:\\ 0\\.027230751856828744\ \(0\)\
\-\ tibia\\:\\ 0\\.02683876441534868\ \(0\)\
\-\ mr\\:\\ 0\\.02552751640291519\ \(0\)\
\-\ figure\\:\\ 0\\.0244741905442664\ \(0\)\
\-\ epiphysis\\:\\ 0\\.024042995071391828\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.023760102019278077\ \(0\)\
\-\ non\\-enhancing\\:\\ 0\\.022241882527018267\ \(0\)\
\-\ intensity\\:\\ 0\\.021119115735926845\ \(0\)\
\-\ tissues\\:\\ 0\\.02098355135551885\ \(0\)\
\-\ soft\\:\\ 0\\.019564268721306878\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.017442551648759626\ \(0\)\
\-\ detection\\:\\ 0\\.016975626742757058\ \(0\)\
\-\ tibial\\:\\ 0\\.016871726382525282\ \(0\)\
\-\ bone\\:\\ 0\\.016334112934306692\ \(0\)\
\-\ t1\\-weighted\\:\\ 0\\.016028663380927885\ \(0\)\
\-\ staphylococcus\\:\\ 0\\.015192683759154703\ \(0\)\
\-\ centers\\:\\ 0\\.014678143514379955\ \(0\)\
\-\ plate\\:\\ 0\\.014642457883122195\ \(0\)\
\-\ swelling\\:\\ 0\\.014599030071698115\ \(0\)\
\-\ aureus\\:\\ 0\\.01445503741953475\ \(0\)\
\-\ localized\\:\\ 0\\.014227548970287095\ \(0\)\
\-\ into\\:\\ 0\\.013903086276647568\ \(0\)\
\-\ epiphyseal\\:\\ 0\\.013798797998670134\ \(0\)\
\-\ tendon\\:\\ 0\\.013631469014236572\ \(0\)\
\-\ debridement\\:\\ 0\\.01356194333166753\ \(0\)\
\-\ signal\\:\\ 0\\.013479931890520899\ \(0\)\
\-\ lesion\\:\\ 0\\.013388886353849652\ \(0\)\
\-\ low\\-intensity\\:\\ 0\\.013191292538971604\ \(0\)\
\-\ growth\\:\\ 0\\.012703083747495042\ \(0\)\
\-\ 2\\.1cm\\:\\ 0\\.012699528312558304\ \(0\)\
\-\ extends\\:\\ 0\\.012661643198666514\ \(0\)\
\-\ surrounded\\:\\ 0\\.012522289208313261\ \(0\)\
\-\ rim\\:\\ 0\\.012365885103250164\ \(0\)\
\-\ defined\\:\\ 0\\.012309684329427393\ \(0\)\
\-\ periphery\\:\\ 0\\.0122370952721332\ \(0\)\
\-\ distal\\:\\ 0\\.011914249174082188\ \(0\)\
\-\ 15\\:\\ 0\\.011652467188055998\ \(0\)\
\-\ adjacent\\:\\ 0\\.011546308735616528\ \(0\)\
\-\ a\\:\\ 0\\.011525122446010635\ \(0\)\
\-\ thick\\:\\ 0\\.01149944893251325\ \(0\)\
\-\ histopathologic\\:\\ 0\\.01113321936918368\ \(0\)\
\-\ extend\\:\\ 0\\.010981843412341647\ \(0\)\
\-\ infection\\:\\ 0\\.010615455444755588\ \(0\)\
\-\ ankle\\:\\ 0\\.010437400757957047\ \(0\)\
\-\ tissue\\:\\ 0\\.010386775325397916\ \(0\)\
\-\ radiopharmaceutical\\:\\ 0\\.010226162529761166\ \(0\)\
\-\ a\\-p\\:\\ 0\\.010036033238974458\ \(0\)\
\-\ longus\\:\\ 0\\.009864950403834316\ \(0\)\
\-\ lytic\\:\\ 0\\.009807912403045543\ \(0\)\
\-\ x\\:\\ 0\\.00963783362511958\ \(0\)\
\-\ nonossifying\\:\\ 0\\.009636691613023166\ \(0\)\
\-\ may\\:\\ 0\\.009611940353323712\ \(0\)\
\-\ inflammation\\:\\ 0\\.00931726890685747\ \(0\)\
\-\ aspect\\:\\ 0\\.009177066442678145\ \(0\)\
\-\ the\\:\\ 0\\.00909845719844375\ \(0\)\
\-\ uptake\\:\\ 0\\.008705085704344133\ \(0\)\
\-\ imaging\\:\\ 0\\.008555871044682063\ \(0\)\
\-\ fibula\\:\\ 0\\.008487813371378529\ \(0\)\
\-\ \\,\\:\\ 0\\.008329540477454997\ \(0\)\
\-\ medially\\:\\ 0\\.008314999496384735\ \(0\)\
\-\ conventional\\:\\ 0\\.008282438479340815\ \(0\)\
\-\ abscesses\\:\\ 0\\.008250486115217476\ \(0\)\
\-\ chronic\\:\\ 0\\.008229024386006837\ \(0\)\
\-\ fibroma\\:\\ 0\\.008128334040034324\ \(0\)\
\-\ low\\:\\ 0\\.00812365146279111\ \(0\)\
\-\ cortical\\:\\ 0\\.007987371411732851\ \(0\)\
\-\ months\\:\\ 0\\.00797928647757288\ \(0\)\
\-\ sensitive\\:\\ 0\\.007933557528326257\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.007831473366443143\ \(0\)\
\-\ lesions\\:\\ 0\\.007820719679808368\ \(0\)\
\-\ lucent\\:\\ 0\\.007806877234046391\ \(0\)\
\-\ across\\:\\ 0\\.007806877234046391\ \(0\)\
\-\ longitudinal\\:\\ 0\\.007643953849765494\ \(0\)\
\-\ fibroconnective\\:\\ 0\\.007534631131595298\ \(0\)\
\-\ bilocular\\:\\ 0\\.007534631131595298\ \(0\)\
\-\ signal\\-intensity\\:\\ 0\\.007534631131595298\ \(0\)\
\-\ anterior\\-tibial\\:\\ 0\\.007534631131595298\ \(0\)\
\-\ 1830\\:\\ 0\\.007534631131595298\ \(0\)\
\-\ possesses\\:\\ 0\\.007534631131595298\ \(0\)\
\-\ cultures\\:\\ 0\\.007515688574649401\ \(0\)\
\-\ subacute\\:\\ 0\\.007495216453202024\ \(0\)\
\-\ antibiotic\\:\\ 0\\.007474986611070396\ \(0\)\
\-\ masses\\:\\ 0\\.007406647174348941\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.007396379579887793\ \(0\)\
\-\ more\\:\\ 0\\.007306585672862107\ \(0\)\
\-\ by\\:\\ 0\\.00729677386279423\ \(0\)\
\-\ metaphysis\\:\\ 0\\.007266957662390876\ \(0\)\
\-\ initial\\:\\ 0\\.007260467034049508\ \(0\)\
\-\ showed\\:\\ 0\\.007184110943394094\ \(0\)\
\-\ consistent\\:\\ 0\\.007163412884893003\ \(0\)\
\-\ medial\\:\\ 0\\.007008460291256543\ \(0\)\
\-\ rarely\\:\\ 0\\.0070034522267887235\ \(0\)\
\-\ are\\:\\ 0\\.006969330861288216\ \(0\)\
\-\ border\\:\\ 0\\.006958267171971364\ \(0\)\
\-\ 2\\.3cm\\:\\ 0\\.0069421976439372245\ \(0\)\
\-\ collins\\:\\ 0\\.0069421976439372245\ \(0\)\
\-\ high\\-intensity\\:\\ 0\\.0069421976439372245\ \(0\)\
\-\ youth\\:\\ 0\\.0069421976439372245\ \(0\)\
\-\ periosteal\\:\\ 0\\.006928793998579046\ \(0\)\
\-\ found\\:\\ 0\\.006905193883210544\ \(0\)\
\-\ involve\\:\\ 0\\.006885515694332397\ \(0\)\
\-\ image\\:\\ 0\\.006844074785378464\ \(0\)\
\-\ show\\:\\ 0\\.006726040857670836\ \(0\)\
\-\ component\\:\\ 0\\.006671561603812729\ \(0\)\
\-\ reaction\\:\\ 0\\.0066342640868988145\ \(0\)\
\-\ as\\:\\ 0\\.00662860259432886\ \(0\)\
\-\ well\\:\\ 0\\.006608823770832995\ \(0\)\
\-\ meta\\-epiphysis\\:\\ 0\\.006595646269485802\ \(0\)\
\-\ sir\\:\\ 0\\.006595646269485802\ \(0\)\
\-\ traumatized\\:\\ 0\\.006595646269485802\ \(0\)\
\-\ benign\\-appearing\\:\\ 0\\.006349764156279152\ \(0\)\
\-\ posteromedially\\:\\ 0\\.006349764156279152\ \(0\)\
\-\ high\\-signal\\:\\ 0\\.006349764156279152\ \(0\)\
\-\ 5\\.5cm\\:\\ 0\\.006349764156279152\ \(0\)\
\-\ sprained\\:\\ 0\\.006349764156279152\ \(0\)\
\-\ traverse\\:\\ 0\\.006349764156279152\ \(0\)\
\-\ sequestra\\:\\ 0\\.006349764156279152\ \(0\)\
\-\ lateral\\:\\ 0\\.006313395027776241\ \(0\)\
\-\ axial\\:\\ 0\\.006253311477097107\ \(0\)\
\-\ measures\\:\\ 0\\.006250364315815332\ \(0\)\
\-\ cortex\\:\\ 0\\.006250364315815332\ \(0\)\
\-\ site\\:\\ 0\\.006173524336563594\ \(0\)\
\-\ low\\-signal\\:\\ 0\\.006159043172249913\ \(0\)\
\-\ benjamin\\:\\ 0\\.006159043172249913\ \(0\)\
\-\ delineating\\:\\ 0\\.006159043172249913\ \(0\)\
\-\ alternate\\:\\ 0\\.006159043172249913\ \(0\)\
\-\ after\\:\\ 0\\.0060444485559288975\ \(0\)\
\-\ bacteremia\\:\\ 0\\.006003212781827729\ \(0\)\
\-\ high\\:\\ 0\\.005996271951479015\ \(0\)\
\-\ presenting\\:\\ 0\\.005953503642224152\ \(0\)\
\-\ at\\:\\ 0\\.005937246937598118\ \(0\)\
\-\ treatment\\:\\ 0\\.005913220374703887\ \(0\)\
\-\ includes\\:\\ 0\\.005888684437331343\ \(0\)\
\-\ 1\\.6cm\\:\\ 0\\.005871460064026654\ \(0\)\
\-\ digitorum\\:\\ 0\\.005871460064026654\ \(0\)\
\-\ skeletally\\:\\ 0\\.005871460064026654\ \(0\)\
\-\ maturation\\:\\ 0\\.005871460064026654\ \(0\)\
\-\ transverse\\:\\ 0\\.005857173836153842\ \(0\)\
\-\ \\:\\:\\ 0\\.005796281107644436\ \(0\)\
\-\ is\\:\\ 0\\.005767084906510006\ \(0\)\
\-\ hdp\\:\\ 0\\.005757330668621078\ \(0\)\
\-\ unfused\\:\\ 0\\.005757330668621078\ \(0\)\
\-\ leg\\:\\ 0\\.0057439270232629005\ \(0\)\
\-\ rims\\:\\ 0\\.005656661407376307\ \(0\)\
\-\ sterile\\:\\ 0\\.005656661407376307\ \(0\)\
\-\ be\\:\\ 0\\.00563143898864927\ \(0\)\
\-\ process\\:\\ 0\\.005624043563820025\ \(0\)\
\-\ precipitating\\:\\ 0\\.00556660968459184\ \(0\)\
\-\ radiolucency\\:\\ 0\\.00556660968459184\ \(0\)\
\-\ commonly\\:\\ 0\\.005512019561462635\ \(0\)\
\-\ low\\-signal\\-intensity\\:\\ 0\\.005485147992451391\ \(0\)\
\-\ granulation\\:\\ 0\\.005410779294169656\ \(0\)\
\-\ unilocular\\:\\ 0\\.005410779294169656\ \(0\)\
\-\ expands\\:\\ 0\\.005342366723508514\ \(0\)\
\-\ high\\-signal\\-intensity\\:\\ 0\\.005342366723508514\ \(0\)\
\-\ ap\\:\\ 0\\.005342152084858868\ \(0\)\
\-\ early\\:\\ 0\\.005342152084858868\ \(0\)\
\-\ sclerosis\\:\\ 0\\.005246692706711701\ \(0\)\
\-\ medium\\:\\ 0\\.005220058310140417\ \(0\)\
\-\ correspond\\:\\ 0\\.005220058310140417\ \(0\)\
\-\ extension\\:\\ 0\\.005214234737062656\ \(0\)\
\-\ saturated\\:\\ 0\\.005164897180963006\ \(0\)\
\-\ typically\\:\\ 0\\.005156283366676876\ \(0\)\
\-\ or\\:\\ 0\\.005136014097249782\ \(0\)\
\-\ malleolus\\:\\ 0\\.005113081264880583\ \(0\)\
\-\ distinguishing\\:\\ 0\\.005113081264880583\ \(0\)\
\-\ to\\:\\ 0\\.005110216682223768\ \(0\)\
\-\ inflammatory\\:\\ 0\\.005065497340499186\ \(0\)\
\-\ long\\:\\ 0\\.0050362760868935446\ \(0\)\
\-\ pathogenesis\\:\\ 0\\.005018016619487229\ \(0\)\
\-\ insidious\\:\\ 0\\.005018016619487229\ \(0\)\
\-\ characteristically\\:\\ 0\\.005018016619487229\ \(0\)\
\-\ for\\:\\ 0\\.004985354862514292\ \(0\)\
\-\ hallucis\\:\\ 0\\.0049741761969337665\ \(0\)\
\-\ thickening\\:\\ 0\\.004951494990928806\ \(0\)\
\-\ although\\:\\ 0\\.0049332124454300914\ \(0\)\
\-\ immature\\:\\ 0\\.004932475201917158\ \(0\)\
\-\ plates\\:\\ 0\\.0048927145047933185\ \(0\)\
\-\ accuracy\\:\\ 0\\.0048927145047933185\ \(0\)\
\-\ tracts\\:\\ 0\\.0048927145047933185\ \(0\)\
\-\ anteroposterior\\:\\ 0\\.004854721545331067\ \(0\)\
\-\ anteromedial\\:\\ 0\\.004854721545331067\ \(0\)\
\-\ grafting\\:\\ 0\\.004854721545331067\ \(0\)\
\-\ channel\\:\\ 0\\.004818345806511583\ \(0\)\
\-\ feature\\:\\ 0\\.004818345806511583\ \(0\)\
\-\ surrounding\\:\\ 0\\.004801991904897035\ \(0\)\
\-\ today\\:\\ 0\\.004783455212904528\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.004752199985370499\ \(0\)\
\-\ 3cm\\:\\ 0\\.004749933235850441\ \(0\)\
\-\ pyogenic\\:\\ 0\\.004749933235850441\ \(0\)\
\-\ regression\\:\\ 0\\.004749933235850441\ \(0\)\
\-\ grew\\:\\ 0\\.004717676545266811\ \(0\)\
\-\ predominant\\:\\ 0\\.004717676545266811\ \(0\)\
\-\ together\\:\\ 0\\.004686593088710508\ \(0\)\
\-\ proximally\\:\\ 0\\.004686593088710508\ \(0\)\
\-\ granulomas\\:\\ 0\\.004686593088710508\ \(0\)\
\-\ in\\:\\ 0\\.004682191446002832\ \(0\)\
\-\ findings\\:\\ 0\\.004663684450743486\ \(0\)\
\-\ often\\:\\ 0\\.004660638544478038\ \(0\)\
\-\ eccentric\\:\\ 0\\.004656600507675234\ \(0\)\
\-\ radiograph\\:\\ 0\\.004652903681916859\ \(0\)\
\-\ radiographs\\:\\ 0\\.004626104002054928\ \(0\)\
\-\ right\\:\\ 0\\.004623752354412394\ \(0\)\
\-\ known\\:\\ 0\\.0046223095460919995\ \(0\)\
\-\ area\\:\\ 0\\.004618523494246611\ \(0\)\
\-\ surgical\\:\\ 0\\.0046056968467985985\ \(0\)\
\-\ unchanged\\:\\ 0\\.004599599332890045\ \(0\)\
\-\ flexor\\:\\ 0\\.004599599332890045\ \(0\)\
\-\ post\\-contrast\\:\\ 0\\.004599599332890045\ \(0\)\
\-\ enhancing\\:\\ 0\\.004581117150230358\ \(0\)\
\-\ maintained\\:\\ 0\\.004572463693304933\ \(0\)\
\-\ tortuous\\:\\ 0\\.004572463693304933\ \(0\)\
\-\ recognized\\:\\ 0\\.004546163130341895\ \(0\)\
\-\ provides\\:\\ 0\\.00452064777722251\ \(0\)\
\-\ furthermore\\:\\ 0\\.004471794432060161\ \(0\)\
\-\ x\\-rays\\:\\ 0\\.004425583131829156\ \(0\)\
\-\ physis\\:\\ 0\\.004403381861399019\ \(0\)\
\-\ lucencies\\:\\ 0\\.004381742709275694\ \(0\)\
\-\ confirmation\\:\\ 0\\.004381742709275694\ \(0\)\
\-\ 6\\:\\ 0\\.004362598566452777\ \(0\)\
\-\ there\\:\\ 0\\.004347745492187995\ \(0\)\
\-\ on\\:\\ 0\\.004330971868852989\ \(0\)\
\-\ diagnoses\\:\\ 0\\.004319930178011056\ \(0\)\
\-\ resolve\\:\\ 0\\.004319930178011056\ \(0\)\
\-\ decade\\:\\ 0\\.004300281017135245\ \(0\)\
\-\ resonance\\:\\ 0\\.004281073448030922\ \(0\)\
\-\ usual\\:\\ 0\\.004262288057672994\ \(0\)\
\-\ evaluation\\:\\ 0\\.004243143240729586\ \(0\)\
\-\ males\\:\\ 0\\.00420828899645801\ \(0\)\
\-\ images\\:\\ 0\\.004203240748588087\ \(0\)\
\-\ visit\\:\\ 0\\.0041910217252464545\ \(0\)\
\-\ magnetic\\:\\ 0\\.0041910217252464545\ \(0\)\
\-\ tc\\-99m\\:\\ 0\\.004174096402771088\ \(0\)\
\-\ focal\\:\\ 0\\.004171783938698123\ \(0\)\
\-\ through\\:\\ 0\\.004148644475933109\ \(0\)\
\-\ region\\:\\ 0\\.0041258140636569445\ \(0\)\
\-\ sensitivity\\:\\ 0\\.004125243057608738\ \(0\)\
\-\ provide\\:\\ 0\\.004094159601052434\ \(0\)\
\-\ evaluating\\:\\ 0\\.004064167020017162\ \(0\)\
\-\ emboli\\:\\ 0\\.003953729642683822\ \(0\)\
\-\ excluded\\:\\ 0\\.003953729642683822\ \(0\)\
\-\ diaphysis\\:\\ 0\\.003928214289564437\ \(0\)\
\-\ therapy\\:\\ 0\\.0039053688824625863\ \(0\)\
\-\ due\\:\\ 0\\.003897909663167247\ \(0\)\
\-\ fracture\\:\\ 0\\.0038514091115773993\ \(0\)\
\-\ mild\\:\\ 0\\.0038465871007369863\ \(0\)\
\-\ septic\\:\\ 0\\.0038331496441710833\ \(0\)\
\-\ fragments\\:\\ 0\\.003821976924882747\ \(0\)\
\-\ becomes\\:\\ 0\\.003821976924882747\ \(0\)\
\-\ minimally\\:\\ 0\\.00380006031752092\ \(0\)\
\-\ that\\:\\ 0\\.0037845659706636494\ \(0\)\
\-\ prior\\:\\ 0\\.0037506201234228436\ \(0\)\
\-\ returned\\:\\ 0\\.003737493305535198\ \(0\)\
\-\ and\\:\\ 0\\.003692492425276276\ \(0\)\
\-\ rapid\\:\\ 0\\.003688639960372849\ \(0\)\
\-\ symptoms\\:\\ 0\\.0036404401314498102\ \(0\)\
\-\ extent\\:\\ 0\\.003624621748259073\ \(0\)\
\-\ definitive\\:\\ 0\\.0036071782682324006\ \(0\)\
\-\ acute\\:\\ 0\\.003606631331805975\ \(0\)\
\-\ spaces\\:\\ 0\\.0035985882375883815\ \(0\)\
\-\ erythema\\:\\ 0\\.003590083681303623\ \(0\)\
\-\ granuloma\\:\\ 0\\.003590083681303623\ \(0\)\
\-\ anteriorly\\:\\ 0\\.0035816629151130142\ \(0\)\
\-\ increased\\:\\ 0\\.003573478259486591\ \(0\)\
\-\ aggressive\\:\\ 0\\.0035733243040486002\ \(0\)\
\-\ unusual\\:\\ 0\\.0035328095699506653\ \(0\)\
\-\ invasion\\:\\ 0\\.003517126545447933\ \(0\)\
\-\ systemic\\:\\ 0\\.0034941287224394507\ \(0\)\
\-\ of\\:\\ 0\\.003485156434127859\ \(0\)\
\-\ become\\:\\ 0\\.003479133585985682\ \(0\)\
\-\ our\\:\\ 0\\.0034717335323590885\ \(0\)\
\-\ reactive\\:\\ 0\\.0034571229055562675\ \(0\)\
\-\ dense\\:\\ 0\\.003449910197311939\ \(0\)\
\-\ posteriorly\\:\\ 0\\.003449910197311939\ \(0\)\
\-\ therefore\\:\\ 0\\.003449910197311939\ \(0\)\
\-\ margin\\:\\ 0\\.0034356648533074847\ \(0\)\
\-\ current\\:\\ 0\\.0034216530500804105\ \(0\)\
\-\ period\\:\\ 0\\.0034147323575738986\ \(0\)\
\-\ form\\:\\ 0\\.0034147323575738986\ \(0\)\
\-\ radiotracer\\:\\ 0\\.003407867253559143\ \(0\)\
\-\ improvement\\:\\ 0\\.003407867253559143\ \(0\)\
\-\ scans\\:\\ 0\\.00340105685214959\ \(0\)\
\-\ complaint\\:\\ 0\\.003374345276505056\ \(0\)\
\-\ most\\:\\ 0\\.003372367763637737\ \(0\)\
\-\ can\\:\\ 0\\.0033132006025112302\ \(0\)\
\-\ incidentally\\:\\ 0\\.003311005129365123\ \(0\)\
\-\ this\\:\\ 0\\.0032859391908175487\ \(0\)\
\-\ it\\:\\ 0\\.003283501512022251\ \(0\)\
\-\ sclerotic\\:\\ 0\\.0032693041343485143\ \(0\)\
\-\ clinic\\:\\ 0\\.003263509530087507\ \(0\)\
\-\ open\\:\\ 0\\.003246357766796217\ \(0\)\
\-\ 14\\:\\ 0\\.003218514886082873\ \(0\)\
\-\ marrow\\:\\ 0\\.003213053520186487\ \(0\)\
\-\ demonstrates\\:\\ 0\\.003190805472911429\ \(0\)\
\-\ life\\:\\ 0\\.003186258195499243\ \(0\)\
\-\ young\\:\\ 0\\.0031809984813331075\ \(0\)\
\-\ needed\\:\\ 0\\.0031809984813331075\ \(0\)\
\-\ weighted\\:\\ 0\\.0031757709368737605\ \(0\)\
\-\ do\\:\\ 0\\.003170575170996511\ \(0\)\
\-\ not\\:\\ 0\\.003166201722415219\ \(0\)\
\-\ absent\\:\\ 0\\.0031654107996666285\ \(0\)\
\-\ 2\\:\\ 0\\.0031454777718128994\ \(0\)\
\-\ suspected\\:\\ 0\\.003145059817877125\ \(0\)\
\-\ foci\\:\\ 0\\.0031350632026949103\ \(0\)\
\-\ described\\:\\ 0\\.0031105715311048453\ \(0\)\
\-\ suggest\\:\\ 0\\.0031105715311048453\ \(0\)\
\-\ addition\\:\\ 0\\.003096206472714776\ \(0\)\
\-\ before\\:\\ 0\\.003091471275812541\ \(0\)\
\-\ bones\\:\\ 0\\.0030820788642094677\ \(0\)\
\-\ recurrent\\:\\ 0\\.0030820788642094677\ \(0\)\
\-\ mass\\:\\ 0\\.0030473359152501656\ \(0\)\
\-\ around\\:\\ 0\\.003041045343537365\ \(0\)\
\-\ absence\\:\\ 0\\.0030366053291124894\ \(0\)\
\-\ located\\:\\ 0\\.003006154749930309\ \(0\)\
\-\ where\\:\\ 0\\.0029808908163905276\ \(0\)\
\-\ initially\\:\\ 0\\.002972632772876222\ \(0\)\
\-\ slightly\\:\\ 0\\.0029523301352624553\ \(0\)\
\-\ no\\:\\ 0\\.002941689404115562\ \(0\)\
\-\ additional\\:\\ 0\\.002928586918076921\ \(0\)\
\-\ extensive\\:\\ 0\\.0029208168567937997\ \(0\)\
\-\ symptomatic\\:\\ 0\\.002901695234781378\ \(0\)\
\-\ diagnostic\\:\\ 0\\.002894164782061587\ \(0\)\
\-\ seen\\:\\ 0\\.0028865429317396414\ \(0\)\
\-\ necrosis\\:\\ 0\\.002882992062773252\ \(0\)\
\-\ reveals\\:\\ 0\\.002857476709653866\ \(0\)\
\-\ marked\\:\\ 0\\.0028503243595081255\ \(0\)\
\-\ rare\\:\\ 0\\.0028361967510028173\ \(0\)\
\-\ second\\:\\ 0\\.0028052384061871606\ \(0\)\
\-\ used\\:\\ 0\\.0028018668008102238\ \(0\)\
\-\ radiographic\\:\\ 0\\.0027721063177681485\ \(0\)\
\-\ greater\\:\\ 0\\.0027433473142482916\ \(0\)\
\-\ antibiotics\\:\\ 0\\.0027433473142482916\ \(0\)\
\-\ studies\\:\\ 0\\.00272777856220441\ \(0\)\
\-\ which\\:\\ 0\\.002726742884175297\ \(0\)\
\-\ abnormalities\\:\\ 0\\.0026827048048702704\ \(0\)\
\-\ involvement\\:\\ 0\\.0026768706466904412\ \(0\)\
\-\ extremity\\:\\ 0\\.002671076042429434\ \(0\)\
\-\ sinus\\:\\ 0\\.002671076042429434\ \(0\)\
\-\ they\\:\\ 0\\.0026315778858865863\ \(0\)\
\-\ would\\:\\ 0\\.0025991169901043503\ \(0\)\
\-\ benign\\:\\ 0\\.0025205558692591463\ \(0\)\
\-\ presentation\\:\\ 0\\.002515727038026566\ \(0\)\
\-\ boy\\:\\ 0\\.0024826681879709157\ \(0\)\
\-\ type\\:\\ 0\\.0024620719900400943\ \(0\)\
\-\ followed\\:\\ 0\\.0024486118558792918\ \(0\)\
\-\ palpation\\:\\ 0\\.0024375547695282495\ \(0\)\
\-\ along\\:\\ 0\\.0024137212622722362\ \(0\)\
\-\ central\\:\\ 0\\.0024031037238119307\ \(0\)\
\-\ study\\:\\ 0\\.0024031037238119307\ \(0\)\
\-\ positive\\:\\ 0\\.0023699876840035184\ \(0\)\
\-\ joint\\:\\ 0\\.002361905346189813\ \(0\)\
\-\ revealed\\:\\ 0\\.0023439947776633277\ \(0\)\
\-\ injury\\:\\ 0\\.0023283833691357266\ \(0\)\
\-\ should\\:\\ 0\\.0023283833691357266\ \(0\)\
\-\ differential\\:\\ 0\\.002318769084917034\ \(0\)\
\-\ with\\:\\ 0\\.0023000820940747555\ \(0\)\
\-\ normal\\:\\ 0\\.002289935819827523\ \(0\)\
\-\ such\\:\\ 0\\.002283190418667395\ \(0\)\
\-\ during\\:\\ 0\\.0022350506409605196\ \(0\)\
\-\ tenderness\\:\\ 0\\.002221292583659516\ \(0\)\
\-\ fat\\:\\ 0\\.002221292583659516\ \(0\)\
\-\ usually\\:\\ 0\\.0022178873964673156\ \(0\)\
\-\ only\\:\\ 0\\.002196078340585415\ \(0\)\
\-\ month\\:\\ 0\\.00219112353914582\ \(0\)\
\-\ treated\\:\\ 0\\.00218619729579817\ \(0\)\
\-\ from\\:\\ 0\\.0021648473729131835\ \(0\)\
\-\ 5\\:\\ 0\\.002136889249952276\ \(0\)\
\-\ t2\\:\\ 0\\.0020671698878208136\ \(0\)\
\-\ edema\\:\\ 0\\.0020657465721634965\ \(0\)\
\-\ time\\:\\ 0\\.0020629070318284723\ \(0\)\
\-\ include\\:\\ 0\\.002048849135068621\ \(0\)\
\-\ scan\\:\\ 0\\.0020446764619085284\ \(0\)\
\-\ 4\\:\\ 0\\.0020350187223752525\ \(0\)\
\-\ however\\:\\ 0\\.0020336479107667268\ \(0\)\
\-\ an\\:\\ 0\\.002019939938948256\ \(0\)\
\-\ shows\\:\\ 0\\.002008011709169982\ \(0\)\
\-\ presented\\:\\ 0\\.001990903961557615\ \(0\)\
\-\ if\\:\\ 0\\.001981831994684304\ \(0\)\
\-\ cm\\:\\ 0\\.0019589368528350306\ \(0\)\
\-\ evidence\\:\\ 0\\.0019149081909118613\ \(0\)\
\-\ than\\:\\ 0\\.0019137169700156186\ \(0\)\
\-\ anterior\\:\\ 0\\.0018810195074895192\ \(0\)\
\-\ both\\:\\ 0\\.001865128197167625\ \(0\)\
\-\ over\\:\\ 0\\.0018595235813162073\ \(0\)\
\-\ physical\\:\\ 0\\.0017918848457959301\ \(0\)\
\-\ pain\\:\\ 0\\.0017839455855226233\ \(0\)\
\-\ 1\\:\\ 0\\.001737885784580946\ \(0\)\
\-\ \\;\\:\\ 0\\.0017311292208996526\ \(0\)\
\-\ without\\:\\ 0\\.0017196693729556924\ \(0\)\
\-\ 3\\:\\ 0\\.0017102354929115723\ \(0\)\
\-\ other\\:\\ 0\\.0016834517510277338\ \(0\)\
\-\ small\\:\\ 0\\.0016825429781035202\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0016807283259256758\ \(0\)\
\-\ diagnosis\\:\\ 0\\.001677110539128564\ \(0\)\
\-\ \\.\\:\\ 0\\.0016687816114137138\ \(0\)\
\-\ were\\:\\ 0\\.001658364390333266\ \(0\)\
\-\ lower\\:\\ 0\\.0016426171533024468\ \(0\)\
\-\ contrast\\:\\ 0\\.0016348510143657311\ \(0\)\
\-\ exam\\:\\ 0\\.001604473452948323\ \(0\)\
\-\ multiple\\:\\ 0\\.0015382957294694606\ \(0\)\
\-\ presents\\:\\ 0\\.0014920036713742956\ \(0\)\
\-\ patient\\:\\ 0\\.0014642597109681846\ \(0\)\
\-\ within\\:\\ 0\\.001393274708022292\ \(0\)\
\-\ \\(\\:\\ 0\\.0012348063696476248\ \(0\)\
\-\ \\)\\:\\ 0\\.0012197225506210344\ \(0\)\
\-\ disease\\:\\ 0\\.0011937927702698327\ \(0\)\
\-\ was\\:\\ 0\\.000844681642917681\ \(0\)\
\-\ year\\:\\ 0\\.000817183990831551\ \(0\)\
\-\ old\\:\\ 0\\.0007478073477455168\ \(0\)\
